FH FORM Holdings Corp

XpresSpa Group Announces New Agreement with Hawaiian Airlines and the State of Hawai‘i as a Trusted Partner for COVID-19 Testing with XpresCheck Testing Facilities

XpresSpa Group Announces New Agreement with Hawaiian Airlines and the State of Hawai‘i as a Trusted Partner for COVID-19 Testing with XpresCheck Testing Facilities

XpresCheck Testing Centers will start offering on-site testing from select cities for non-stop flights to Hawai‘i

NEW YORK and HONOLULU, Dec. 28, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced a partnership with Hawaiian Airlines to start offering COVID-19 testing services for passengers leaving John F. Kennedy International Airport (JFK), Boston Logan International Airport (BOS) and Phoenix Sky Harbor Airport (PHX). Beginning today, its subsidiary, XpresCheck, will begin serving as a trusted testing partner for the carrier’s guests traveling on its non-stop flights to Hawai‘i.

“We are very pleased to be welcomed as a trusted partner of Hawaiian Airlines and the state of Hawai’i so more travelers can safely return to vacation travel during the COVID-19 pandemic.  Our growing network of airline partners are providing more travelers more access to more destinations heading into 2021,” said XpresSpa Group’s Chief Executive Officer, Doug Satzman.

XpresCheck, will provide pre-travel testing on-site with rapid molecular testing services – with results provided while you wait – so travelers may bypass the state of Hawaiʻi 10-day quarantine restriction. Guests may access the walk-up testing site and purchase a $200 state-approved rapid test at the following airport locations:

  • JFK: Terminal 4
  • BOS: Terminal E
  • PHX: Terminal 4

Passengers who test positive from a rapid test are informed that they must exit the airport and self-isolate per CDC guidelines. Any travel companions will also not be permitted to travel. As more destinations mandate testing requirements, partnerships between airport testing facilities and airlines will continue to pave the way to restoring traveler confidence and safety in 2021.

“Our collaboration with XpresCheck furthers our commitment to making pre-travel testing seamless and accessible for our guests returning home or taking a long-awaited Hawai'i vacation from Phoenix, New York City and Boston while also doing our part to maintain Hawaiʻi track-record as a safe destination,” said Avi Mannis, senior vice president of marketing at Hawaiian Airlines.

Passengers should visit to make appointments.

About Hawaiian Airlines

Hawaiian® has led all U.S. carriers in on-time performance for each of the past 16 years (2004-2019) as reported by the U.S. Department of Transportation. Consumer surveys by Condé Nast Traveler, Travel + Leisure and TripAdvisor have placed Hawaiian among the top of all domestic airlines serving Hawai‘i.

Now in its 92nd year of continuous service, Hawaiian is Hawai‘i's biggest and longest-serving airline. In 2019, Hawaiian offered nonstop flights between Hawai‘i and more U.S. gateway cities (13) than any other airline, along with service connecting the islands with Japan, South Korea, Australia, New Zealand, American Samoa and Tahiti. As a result of the COVID-19 pandemic, Hawaiian is offering an adjusted schedule of daily flights within the Hawaiian Islands, and between Hawai‘i and the U.S. mainland as well as Japan and South Korea.

The airline is committed to the health and safety of its guests and employees and has reinforced enhanced cleaning procedures across its business. While the experience may be a little different, the authentic Hawaiian hospitality remains unchanged. Additional details on how Hawaiian is keeping guests and employees safe can be found at .

Hawaiian Airlines, Inc. is a subsidiary of Hawaiian Holdings, Inc. (NASDAQ: HA). Additional information is available at . Follow Hawaiian’s Twitter updates (), become a fan on Facebook (), and follow us on Instagram (). For career postings and updates, follow Hawaiian’s  page.



About XpresSpa Group, Inc.

XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company. XpresSpa Group’s core asset, XpresSpa, is a leading airport retailer of spa services and related health and wellness products, with 50 locations in 25 airports globally. Through its XpresTest, Inc. subsidiary, the Company also provides COVID-19 screening and testing under its XpresCheck™ brand at JFK International Airport, Newark Liberty International Airport, Logan International Airport, Sky Harbor International Airport, and Denver International Airport. To learn more about XpresSpa Group, visit: To learn more about XpresSpa, visit To learn more about XpresCheck, visit

Forward-Looking Statements

Forward-Looking Statements This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa Group as of today's date and are not guarantees of the future performance of the company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa Group’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, recent Current Reports on Form 8-K and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa Group, or other matters and attributable to XpresSpa Group or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa Group does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

For media inquiries, please visit Hawaiian Airlines’ .

Media - XpresSpa

Julie Ferguson



(312) 385-0098

Investor Relations - XpresSpa

ICR

Raphael Gross



(203) 682-8253

Media - Hawaiian Airlines

Hawaiian Airlines Public Relations



EN
28/12/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on FORM Holdings Corp

 PRESS RELEASE

XWELL Announces Approximately $31.3 Million Private Placement Priced ...

XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses. The private placement consists of the sale of, (i) ap...

 PRESS RELEASE

XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CD...

XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone Predictive intelligence platform strengthens biosurveillance prioritization and planning ahead of major global travel events NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (Nasdaq: XWEL), a provider of wellness and biosecurity solutions, today announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention (CDC). The announcement follows a recent  for th...

 PRESS RELEASE

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior ...

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor Company Builds on U.S Biosecurity Leadership to Advance Pathogen Surveillance Internationally NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of g...

 PRESS RELEASE

XWELL Expands Beyond Airports with New Wellness Retail Location in New...

XWELL Expands Beyond Airports with New Wellness Retail Location in New York City’s Pennsylvania Station Bringing Accessible Self-Care to One of the Nation’s Busiest Commuter Hubs NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go, is excited to announce the opening of its newest location inside New York City’s Pennsylvania Station—a major step in expanding the brand beyond airport terminals and into high-traffic city spaces. “Our entry into Penn Station marks a natural next step for ...

 PRESS RELEASE

XWELL Reports Third Quarter 2025 Results

XWELL Reports Third Quarter 2025 Results NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the third quarter ended September 30, 2025. Recent Operating Highlights Revenue for the 2025 third quarter totaled $7.3 million.Cost of sales decreased approximately 8% from the 2024 third quarter.General and administrative expenses, excluding one-time credits, decreased approximately 32% from the 2024 third quarter.The Company’s Priority Pass partnership has ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch